WVE position history
The shares of Wave Life Sciences (WVE) that MAVERICK CAPITAL LTD reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 3,193,389 shares, $16M, 0.16% of portfolio
- 2021 Q4: 5,593,389 shares, $18M, 0.20% of portfolio, Add +75.2%
- 2022 Q1: 5,593,389 shares, $11M, 0.20% of portfolio
- 2022 Q2: 7,805,219 shares, $25M, 0.63% of portfolio, Add +39.5%
- 2022 Q3: 7,805,219 shares, $28M, 0.63% of portfolio
- 2022 Q4: 14,195,328 shares, $99M, 2.3% of portfolio, Add +81.9%
- 2023 Q1: 6,596,778 shares, $29M, 0.72% of portfolio, Reduce −53.5%
- 2023 Q2: 6,596,778 shares, $24M, 0.51% of portfolio
- 2023 Q3: 6,594,319 shares, $38M, 0.86% of portfolio, Reduce 0.0%
- 2023 Q4: 8,447,804 shares, $43M, 0.86% of portfolio, Add +28.1%
- 2024 Q1: 7,688,079 shares, $47M, 0.89% of portfolio, Reduce −9.0%
- 2024 Q2: 7,669,361 shares, $38M, 0.73% of portfolio, Reduce −0.2%
- 2024 Q3: 10,047,520 shares, $82M, 1.6% of portfolio, Add +31.0%
- 2024 Q4: 8,261,242 shares, $102M, 1.8% of portfolio, Reduce −17.8%
- 2025 Q1: 8,261,683 shares, $67M, 1.2% of portfolio, Add 0.0%
- 2025 Q2: 8,261,683 shares, $54M, 0.81% of portfolio
- 2025 Q3: 8,391,856 shares, $61M, 0.82% of portfolio, Add +1.6%
- 2025 Q4: 9,280,237 shares, $158M, 1.7% of portfolio, Add +10.6%
- 2026 Q1: 10,161,399 shares, $74M, 0.85% of portfolio, Add +9.5%
- 2026 Q2: 10,278,115 shares, $60M, 0.53% of portfolio, Add +1.1%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|